BDPO Beta Logo
Charts
Backtesting
The Backtester Lab Codeless Libary Editor Documentation
API
Finance
Finance Portfolio Screener Watchlists Economic Calendar Earnings Calendar News Notifications Congress Trading Institutional Investors Insiders
Community
Explore Forum
Market
Marketplace Submit
Profile
Profile Settings
Pricing
More
Terms FAQ Contact Ticker Request Changelog
BDPO Beta Logo
BDPO Beta Logo
Home Charts
Backtesting
The Backtester Lab Codeless Libary Editor Documentation
API
Finance
Finance Portfolio Screener Watchlists Economic Calendar Earnings Calendar News Notifications Congress Trading Institutional Investors Insiders
Community
Explore Forum
Market
Marketplace Submit
Profile
Profile Settings
Pricing
More
Terms FAQ Contact Ticker Request Changelog
GOOG has hit a 52 week high
Google annnouced there quarterly earnings and beating analysts estimates causing the stock to surge to a new 52 week high.
NOC has hit a 52 week high
Northrop Grumman annnouced there quarterly earnings and beating analysts estimates causing the stock to surge to a new 52 week high.
TSLA is down 2%
Tesla is down 2% today after the company annnouced they will be delaying the new model 3.
MSFT has hit a 52 week high
Microsoft annnouced there quarterly earnings and beating analysts estimates causing the stock to surge to a new 52 week high.

Aisling Capital Management Lp

13F Holdings
Filed: 2025-02-12
Portfolio Value
281.83M arrow_upward 7.95%
Number of Holdings
lock info
Reporting Date
2024-12-31
Key Stats trending_flat
CIK
0001766721
Filing Date
2025-02-12 00:00:00
Address
489 5th Ave, 10th Floor
New York
NY
Prior Value
261.07M
Top 10 Holdings %
lock
Portfolio Value
Aisling Capital Management Lp
(13F - 2024-12-31)
Bridgebio Pharma Inc. (Bbio)
-
2025-02-12
Value
166.51M
Shares
6.07M
Portfolio %
59.08%
Verona Pharma Plc (Vrna)
-
2025-02-12
Value
51.80M
Shares
1.12M
Portfolio %
18.38%
Syndax Pharmaceuticals, Inc. (Sndx)
-
2025-02-12
Value
13.55M
Shares
1.02M
Portfolio %
4.81%
Monte Rosa Therapeutics Inc (Glue)
-
2025-02-12
Value
10.22M
Shares
1.47M
Portfolio %
3.63%
Poseida Therapeutics Inc. (Pstx)
-
2025-02-12
Value
10.02M
Shares
1.04M
Portfolio %
3.55%
Bicara Therapeutics Inc. (Bcax)
-
2025-02-12
Value
9.91M
Shares
568.92K
Portfolio %
3.52%
Nuvation Bio Inc. (Nuvb)
-
2025-02-12
Value
6.76M
Shares
2.54M
Portfolio %
2.40%
Compass Pathways Plc (Cmps)
-
2025-02-12
Value
3.65M
Shares
964.50K
Portfolio %
1.29%
Biomea Fusion Inc (Bmea)
-
2025-02-12
Value
3.10M
Shares
798.76K
Portfolio %
1.10%
Calcimedica, Inc. (Calc)
-
2025-02-12
Value
1.84M
Shares
521.11K
Portfolio %
0.65%
Top Increases | Aisling Capital Management Lp
(2024-09-30 → 2024-12-31)
Verona Pharma Plc (Vrna)
-
2025-02-12
Value Change
arrow_upward 19.71M
Shares
arrow_upward 0.00
Portfolio % Change
arrow_upward 6.09%
Portfolio %
18.38%
Poseida Therapeutics Inc. (Pstx)
-
2025-02-12
Value Change
arrow_upward 7.03M
Shares
arrow_upward 0.00
Portfolio % Change
arrow_upward 2.41%
Portfolio %
3.55%
Monte Rosa Therapeutics Inc (Glue)
-
2025-02-12
Value Change
arrow_upward 2.41M
Shares
arrow_upward 0.00
Portfolio % Change
arrow_upward 0.64%
Portfolio %
3.63%
Aclaris Therapeutics Inc (Acrs)
-
2025-02-12
Value Change
arrow_upward 577.83K
Shares
arrow_upward 0.00
Portfolio % Change
arrow_upward 0.19%
Portfolio %
0.38%
Nuvation Bio Inc. (Nuvb)
-
2025-02-12
Value Change
arrow_upward 940.17K
Shares
arrow_upward 0.00
Portfolio % Change
arrow_upward 0.17%
Portfolio %
2.40%
Marker Therapeutics, Inc. (Mrkr)
-
2025-02-12
Value Change
arrow_upward 125.61K
Shares
arrow_upward 11.08K
Portfolio % Change
arrow_upward 0.02%
Portfolio %
0.36%
Top Decreases | Aisling Capital Management Lp
(2024-09-30 → 2024-12-31)
Viracta Therapeutics Inc (Virx)
-
2025-02-12
Value Change
arrow_downward -20200.00
Shares
arrow_downward 0.00
Portfolio % Change
arrow_downward 0.01%
Portfolio %
0.02%
Elevation Oncology Inc (Elev)
-
2025-02-12
Value Change
arrow_downward -113396.00
Shares
arrow_downward 0.00
Portfolio % Change
arrow_downward 0.09%
Portfolio %
0.56%
Bridgebio Pharma Inc. (Bbio)
-
2025-02-12
Value Change
arrow_downward 12.01M
Shares
arrow_downward 0.00
Portfolio % Change
arrow_downward 0.10%
Portfolio %
59.08%
Calcimedica, Inc. (Calc)
-
2025-02-12
Value Change
arrow_downward -463791.00
Shares
arrow_downward 0.00
Portfolio % Change
arrow_downward 0.23%
Portfolio %
0.65%
Compass Pathways Plc (Cmps)
-
2025-02-12
Value Change
arrow_downward -2430540.00
Shares
arrow_downward 0.00
Portfolio % Change
arrow_downward 1.03%
Portfolio %
1.29%
Biomea Fusion Inc (Bmea)
-
2025-02-12
Value Change
arrow_downward -4968269.00
Shares
arrow_downward 0.00
Portfolio % Change
arrow_downward 1.99%
Portfolio %
1.10%
Bicara Therapeutics Inc. (Bcax)
-
2025-02-12
Value Change
arrow_downward -4579798.00
Shares
arrow_downward 0.00
Portfolio % Change
arrow_downward 2.03%
Portfolio %
3.52%
Syndax Pharmaceuticals, Inc. (Sndx)
-
2025-02-12
Value Change
arrow_downward -6180750.00
Shares
arrow_downward 0.00
Portfolio % Change
arrow_downward 2.75%
Portfolio %
4.81%
Aisling Capital Management Lp (13F - 2024-12-31) Comparing to 2024-09-30
New/Increased Position added or increased from previous period Closed/Decreased Position closed or decreased from previous period
arrow_upward Increase arrow_downward Decrease
Company Ticker Type Shares Value Current % Previous % % Change $ Change $ Change % Shares Change Status Qtr End Price Filing Date
New Positions | Aisling Capital Management Lp
(2024-09-30 → 2024-12-31)
Onkure Therapeutics, Inc. (Okur)
-
2025-02-12
Value
add_circle 762.02K
Shares
88.61K
Portfolio %
0.27%
% Change
0.27%
Closed Positions | Aisling Capital Management Lp
(2024-09-30 → 2024-12-31)
Reneo Pharmaceuticals Inc (Rphm)
-
2024-11-13
Value
remove_circle 1.51M
Shares
886.08K
Previous %
59.18%
% Change
-59.18%
Tectonic Therapeutic Inc (Tecx)
TECX
2024-11-13
Value
remove_circle 2.55M
Shares
84.15K
Previous %
59.18%
% Change
-59.18%